Influenza News and Research

Latest Influenza News and Research

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

An independent lab report demonstrated that BIOGUARD™ barrier gauze dressings exhibit greater than 99.9% inactivation rates against swine flu virus after exposure for 24 hours.

8 Dec 2009

New data from NanoBio's nanoemulsion-based adjuvant platform to be presented

NanoBio Corporation announced today that its CEO and Founder, James R. Baker, Jr., M.D., will present new data from studies of its nanoemulsion-based adjuvant platform during the World Influenza Congress, taking place from December 7-9, 2009 in Brussels, Belgium.

8 Dec 2009

H1N1 virus produces pulmonary damage similar to earlier flu pandemics

In fatal cases of 2009 H1N1 influenza, the virus can damage cells throughout the respiratory airway, much like the viruses that caused the 1918 and 1957 influenza pandemics, report researchers from the National Institutes of Health (NIH) and the New York City Office of Chief Medical Examiner.

8 Dec 2009

Human blood stem cells can be engineered to kill HIV-infected cells, find researchers

Researchers from the UCLA AIDS Institute and colleagues have for the first time demonstrated that human blood stem cells can be engineered into cells that can target and kill HIV-infected cells — a process that potentially could be used against a range of chronic viral diseases.

8 Dec 2009

Amgen announces results from first Phase 1/2 study of Nplate

Amgen Inc. today announced results from its first Phase 1/2 study evaluating the safety and efficacy of Nplate® (romiplostim) in children with chronic immune thrombocytopenic purpura (ITP).

8 Dec 2009

La Jolla Pharmaceutical enters into definitive merger agreement with Adamis Pharmaceuticals

La Jolla Pharmaceutical Company (“La Jolla”) today announced that it entered into a definitive merger agreement with Adamis Pharmaceuticals Corporation (“Adamis”) on December 4, 2009.

8 Dec 2009

Adamis Pharmaceuticals to acquire La Jolla Pharmaceutical Company

Adamis Pharmaceuticals Corporation (OTCBB: ADMP), announced today that it has entered into a definitive merger agreement providing for the acquisition of La Jolla Pharmaceutical Company by Adamis.

7 Dec 2009

Computer search algorithms identify FDA-approved drugs that could be the basis for new medicines

A massive, data-crunching computer search program that matches fragments of potential drug molecules to the known shapes of viral surface proteins has identified several FDA-approved drugs that could be the basis for new medicines -- if emerging viruses such as the H5N1(avian flu) or H1N1/09 (swine flu) develop resistance to current antiviral therapies -- according to a presentation at the American Society for Cell Biology (ASCB) 49th Annual Meeting, Dec. 5-9, 2009 in San Diego.

7 Dec 2009

CDC announces the start of National Influenza Vaccination Week

Today the Centers for Disease Control and Prevention (CDC) announced the start of National Influenza Vaccination Week. While the week was designed to highlight the importance of flu vaccinations, it also brings to light the importance of taking additional steps to keep you and your family healthy during the peak cold and flu season of December, January and beyond.

7 Dec 2009

Phase I/II clinical trial of Multimeric-001 Universal Flu Vaccine successful

BiondVax Pharmaceuticals Ltd., an Israeli biopharmaceutical company at the forefront of the development of a Universal Influenza Vaccine, announced the success of the Phase I/II clinical trial of the Company's Multimeric-001 Universal Flu Vaccine, in trials conducted at the Sourasky Medical Center in Tel Aviv, Israel.

7 Dec 2009

Amgen announces results from three studies on the safety and efficacy of Nplate

Amgen Inc. today announced results from three studies on the safety and efficacy of Nplate® (romiplostim) in adult patients with myelodysplastic syndromes (MDS).

7 Dec 2009

Findings underscore the need for additional medical student education for healthcare reform

As the population of people with chronic conditions and health care costs rise, so do opportunities for implementing health prevention strategies. Jan Carney, M.D., M.P.H., associate dean for public health at the University of Vermont (UVM) College of Medicine, believes a critical strategy for reforming the health care system lies in teaching medical students about prevention and public health.

5 Dec 2009

Tips to prevent H1N1 infection

National Handwashing Awareness Week is from Dec. 6 to 12, and a Geisinger physician advises that with the presence of the H1N1 virus this year, handwashing is more important than ever.

5 Dec 2009

Too early to declare end of H1N1 pandemic, WHO says

Though there are signs the H1N1 (swine flu) has peaked in the U.S. and Canada, a WHO flu expert said Thursday it is too early to declare the pandemic over, Canadian Press reports.

4 Dec 2009

Eastern Technology Council names Puricore as winner of the Emerging Life Sciences Company of the Year

PuriCore, the life sciences company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment, was named as winner of the Emerging Life Sciences Company of the Year award, at the Eastern Technology Council’s 17th annual Enterprise Awards gala.

4 Dec 2009

New study shows seasonal flu vaccine awareness is high among Hispanics, but vaccination rates are lower

Although there is high awareness of the need for seasonal influenza vaccines, a new study of Hispanics in one California county shows low rates of actual vaccination, especially among men.

4 Dec 2009

Study reveals that majority of all vaccine preventable deaths occur in those 65 and older

Ninety percent of all vaccine preventable deaths occur in those 65 and older, including residents in nursing homes, according to highlighted studies in the Pennsylvania Patient Safety Authority's 2009 December Patient Safety Advisory.

4 Dec 2009

Adaptive vaccination strategies outperform seasonal influenza vaccination allocation strategies

Adaptive vaccination strategies, based on age patterns of hospitalizations and deaths monitored in real-time during the early stages of a pandemic, outperform seasonal influenza vaccination allocation strategies, according to findings reported Dec. 3 by researchers, including two from Arizona State University, in the online journal PLoS ONE.

4 Dec 2009

Integrative medicine and treatment strategies for the H1N1 infection discussed at the Buchang Forum

According to the World Health Organization, the human H1N1/09 Type A influenza ("Swine Flu") has reached a pandemic level. Over 500,000 cases have been confirmed worldwide with at least 6,500 fatalities. Since there is no longer a requirement to test and report individual cases, these numbers undoubtedly understate the real situation.

4 Dec 2009

Vaccination, social distancing and antiviral drugs may help lessen swine flu impact

The relatively low number of new cases created by a single case of H1N1 influenza indicates that mitigation strategies such as vaccination, social distancing and the use of antiviral drugs may help to lessen the final impact of the virus, suggests an epidemiological modelling study

4 Dec 2009

Influenza News and Research

Latest Influenza News and Research

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

New data from NanoBio's nanoemulsion-based adjuvant platform to be presented

H1N1 virus produces pulmonary damage similar to earlier flu pandemics

Human blood stem cells can be engineered to kill HIV-infected cells, find researchers

Amgen announces results from first Phase 1/2 study of Nplate

La Jolla Pharmaceutical enters into definitive merger agreement with Adamis Pharmaceuticals

Adamis Pharmaceuticals to acquire La Jolla Pharmaceutical Company

Computer search algorithms identify FDA-approved drugs that could be the basis for new medicines

CDC announces the start of National Influenza Vaccination Week

Phase I/II clinical trial of Multimeric-001 Universal Flu Vaccine successful

Amgen announces results from three studies on the safety and efficacy of Nplate

Findings underscore the need for additional medical student education for healthcare reform

Tips to prevent H1N1 infection

Too early to declare end of H1N1 pandemic, WHO says

Eastern Technology Council names Puricore as winner of the Emerging Life Sciences Company of the Year

New study shows seasonal flu vaccine awareness is high among Hispanics, but vaccination rates are lower

Study reveals that majority of all vaccine preventable deaths occur in those 65 and older

Adaptive vaccination strategies outperform seasonal influenza vaccination allocation strategies

Integrative medicine and treatment strategies for the H1N1 infection discussed at the Buchang Forum

Vaccination, social distancing and antiviral drugs may help lessen swine flu impact

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Influenza News and Research

Latest Influenza News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in